Deerfield, IL, United States of America

Robert W Schoenleber


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert W. Schoenleber

Introduction

Robert W. Schoenleber is a notable inventor based in Deerfield, IL (US), recognized for his significant contributions to the field of pharmacology. With a total of 3 patents, he has made strides in developing compounds that target neurological and psychological disorders. His work is particularly focused on dopamine-related treatments, showcasing his commitment to advancing medical science.

Latest Patents

Schoenleber's latest patents include groundbreaking innovations such as the "Tetracyclic spirobenzazepine dopamine antagonists." This patent describes novel tetracyclic spirobenzazepine compounds that serve as dopamine D-1 receptor antagonists. These compounds are useful for treating various conditions, including dopamine-related neurological and psychological disorders, cognitive impairment, attention deficit disorders, and addictive behavior disorders. Another significant patent is for "Dopaminergic compounds," which outlines novel compounds that can be utilized in the development of effective treatments for similar disorders.

Career Highlights

Throughout his career, Robert W. Schoenleber has been associated with Abbott Laboratories Corporation, a leading company in the pharmaceutical industry. His work at Abbott has allowed him to collaborate with other talented professionals and contribute to the development of innovative medical solutions.

Collaborations

Schoenleber has worked alongside esteemed colleagues such as John W. Kebabian and Michael P. DeNinno. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new therapeutic compounds.

Conclusion

Robert W. Schoenleber's contributions to the field of pharmacology through his patents and collaborations highlight his dedication to improving healthcare. His innovative work continues to pave the way for advancements in treating complex neurological and psychological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…